DUSP8 Antibodies

Santa Cruz Biotechnology features a diverse variety of DUSP8 monoclonal antibodies for investigating dual specificity phosphatase 8 (DUSP8). DUSP8 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). DUSP8 is a critical regulator of MAPK signaling pathways, playing a significant role in cellular responses to stress and inflammation. By dephosphorylating both tyrosine and serine/threonine residues, DUSP8 modulates the activity of MAP kinases, influencing processes such as cell proliferation, differentiation, and apoptosis. Understanding DUSP8 function is essential for elucidating its contributions to various diseases, including cancer and autoimmune disorders. Researchers can explore DUSP8's role in different cellular pathways and disease mechanisms. Advanced research techniques enable detailed examination of DUSP8's involvement in signal transduction and cellular regulation. Investigating DUSP8 expression patterns helps reveal its importance in tissue development and homeostasis. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of DUSP8's role in health and disease.